Skip to main navigation Skip to main content

The University of Southampton

×

Immune-boosting antibody combination could improve lymphoma survival (RiVa Study)

Published: 4 December 2017

Combining two different immunotherapy treatments could dramatically improve lymphoma survival, according to a Cancer Research UK funded study published in Cancer Cell

See full news release here

Articles that may also interest you

New trial tests whether a targeted drug can help patients with a hard-to-treat cancer

“I’ve seen the effects of cancer, both personally and through my work” – Senior Trial Manager Josh runs the London Marathon to raise funds for CRUK

Easter closure notice 2024

Share this article Share this on Facebook Share this on Twitter Share this on Weibo

Privacy Settings